Stem Cell Biology and Therapy Laboratory, the Key Laboratory of Pediatrics Designated by Chinese Ministry of Education and Chongqing Bureau of Education, and the Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Int J Med Sci. 2013 Jun 20;10(8):1035-46. doi: 10.7150/ijms.6639. Print 2013.
Progenitor cell-based cardiomyocyte regeneration holds great promise of repairing an injured heart. Although cardiomyogenic differentiation has been reported for a variety of progenitor cell types, the biological factors that regulate effective cardiomyogenesis remain largely undefined. Primary cardiomyogenic progenitors (CPs) have a limited life span in culture, hampering the CPs' in vitro and in vivo studies. The objective of this study is to investigate if primary CPs isolated from fetal mouse heart can be reversibly immortalized with SV40 large T and maintain long-term cell proliferation without compromising cardiomyogenic differentiation potential.
Primary cardiomyocytes were isolated from mouse E15.5 fetal heart, and immortalized retrovirally with the expression of SV40 large T antigen flanked with loxP sites. Expression of cardiomyogenic markers were determined by quantitative RT-PCR and immunofluorescence staining. The immortalization phenotype was reversed by using an adenovirus-mediated expression of the Cre reconbinase. Cardiomyogenic differentiation induced by retinoids or dexamethasone was assessed by an α-myosin heavy chain (MyHC) promoter-driven reporter.
We demonstrate that the CPs derived from mouse E15.5 fetal heart can be efficiently immortalized by SV40 T antigen. The conditionally immortalized CPs (iCP15 clones) exhibit an increased proliferative activity and are able to maintain long-term proliferation, which can be reversed by Cre recombinase. The iCP15 cells express cardiomyogenic markers and retain differentiation potential as they can undergo terminal differentiate into cardiomyctes under appropriate differentiation conditions although the iCP15 clones represent a large repertoire of CPs at various differentiation stages. The removal of SV40 large T increases the iCPs' differentiation potential. Thus, the iCPs not only maintain long-term cell proliferative activity but also retain cardiomyogenic differentiation potential.
Our results suggest that the reported reversible SV40 T antigen-mediated immortalization represents an efficient approach for establishing long-term culture of primary cardiomyogenic progenitors for basic and translational research.
基于祖细胞的心肌细胞再生为修复受损心脏带来了巨大的希望。尽管已经报道了多种祖细胞类型的心肌生成分化,但调节有效心肌生成的生物学因素在很大程度上仍未得到明确。原代心肌祖细胞(CPs)在培养中寿命有限,阻碍了 CPs 的体外和体内研究。本研究旨在探讨是否可以使用 SV40 大 T 使分离自胎鼠心脏的原代 CPs 可逆性永生化,同时保持长期的细胞增殖而不损害心肌生成分化潜能。
从胎鼠 E15.5 心脏中分离原代心肌细胞,并通过表达带有 loxP 位点的 SV40 大 T 抗原的逆转录病毒进行永生化。通过定量 RT-PCR 和免疫荧光染色测定心肌生成标志物的表达。通过使用腺病毒介导的 Cre 重组酶的表达来逆转永生化表型。通过视黄酸或地塞米松诱导的α-肌球蛋白重链(MyHC)启动子驱动的报告基因评估心肌生成分化。
我们证明了源自胎鼠 E15.5 心脏的 CPs 可以被 SV40 T 抗原有效地永生化。条件性永生化的 CPs(iCP15 克隆)表现出增强的增殖活性,并能够长期增殖,通过 Cre 重组酶可以逆转。iCP15 细胞表达心肌生成标志物,并保留分化潜能,因为它们可以在适当的分化条件下经历终末分化为心肌细胞,尽管 iCP15 克隆代表了各种分化阶段的大量 CPs 群体。SV40 大 T 的去除增加了 iCP 的分化潜能。因此,iCP 不仅保持长期的细胞增殖活性,而且保留心肌生成分化潜能。
我们的结果表明,所报道的可逆转的 SV40 T 抗原介导的永生化代表了建立用于基础和转化研究的原代心肌生成祖细胞的长期培养的有效方法。